HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Clinical trials for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets tough leukemia in patients with RUNX1 mutation
Disease control TerminatedThis study tested two drugs, omacetaxine and venetoclax, in 24 adults with acute myeloid leukemia or myelodysplastic syndrome that returned or didn't respond to treatment. All participants had a specific genetic change called RUNX1. The goal was to find the best dose and see if t…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 02:41 UTC
-
Cancer Patients' COVID-19 trial halted after just 4 participants
Disease control TerminatedThis early-stage study tested two drugs, rintatolimod and interferon alpha-2b, in cancer patients with COVID-19. The goal was to see if the combination could boost the immune system to fight the virus. Only 4 people took part before the study was stopped early. The main focus was…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 17, 2026 02:26 UTC
-
Cancer brain metastasis drug combo trial halted early
Disease control TerminatedThis study tested two drugs, bintrafusp alfa and pimasertib, in people whose cancer had spread to the brain. The goal was to find the best dose and see if the combination could slow or stop tumor growth. The trial was stopped early after enrolling only 8 participants, so no clear…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Cancer treatment side effect study halted after just one patient
Disease control TerminatedThis study looked at whether two drugs, infliximab and intravenous immunoglobulin (IVIG), could help cancer patients with severe lung inflammation (pneumonitis) that didn't get better with steroids. The goal was to improve oxygen levels in the blood after 28 days. However, the st…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 06, 2026 16:13 UTC
-
New approaches aim to ease recovery after stem cell transplants in vulnerable patients
Symptom relief TerminatedThis study tested two approaches—supportive and palliative care (focusing on symptom relief and emotional support) and clinical management of other health problems (like heart or lung disease through exercise, diet, and medication management)—to see if they could improve quality …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated May 17, 2026 02:39 UTC
-
Can tech boost depression treatment in cancer care?
Symptom relief TerminatedThis study looked at whether adding technology to collaborative care management helps cancer patients with depression. It involved 297 adults receiving cancer treatment at urban and rural centers. The goal was to see if tech-enhanced care improves treatment engagement and reduces…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated May 11, 2026 20:50 UTC